Insiders who reported open-market trades in the last 12 months at the companies Third Rock Ventures IV, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
Adam Crystal - $6.99M in TNGX purchases and sales in the last 12 months
Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
Atul Dandekar - $2.27M in MAZE purchases and sales in the last 12 months
Catherine A. Sohn - $1.15M in MAZE purchases and sales in the last 12 months
Amy Bachrodt - $757K in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Third Rock Ventures IV, L.P. is an investment firm of Maze Therapeutics, Inc. (MAZE). InsiderAlpha holds 7 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Third Rock Ventures IV, L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 5 November 2025, one of 7 filings going back to 2025.
Has Third Rock Ventures IV, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($26.35M) across all tracked filings.
Third Rock Ventures IV, L.P. files SEC Form 4 reports at Maze Therapeutics, Inc. (MAZE). 7 SEC Form 4 filings on record, most recently on 5 November 2025. Most recent open-market trade: sold $4.85M of TNGX on 27 October 2025. Lifetime open-market sales: $26.35M.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by Third Rock Ventures IV, L.P..
InsiderAlpha's records for Third Rock Ventures IV, L.P. go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
